SIGN UPLog In

Last deal

$16.6M
Local Amount - CAD 21.M

Amount

Venture - Series Unknown

Stage

31.03.2015

Date

6

all rounds

$56.7M

Total amount

General

About Company
Cynapsus is a pharmaceutical company developing a non-injectable drug for Parkinson's disease.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2004

Number of employees

11-50

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The Toronto-based company specializes in healthcare, biotechnology, pharmaceuticals, and therapeutics. It has developed a sublingual thin film for on-demand management of debilitating OFF episodes associated with Parkinson's disease. Cynapsus has completed a Phase two clinical trial for its product candidate, APL-130277, a sublingual formulation of apomorphine hydrochloride.
Contacts

location

Toronto, ON, Canada

Phone number

Website URL

http://cynapsus.ca

Social url